NANBASE C-96 V4.0 (Anti-HCV)

Direct sandwich ELISA qualitative assay for Anti-HCV antibodies. 100% sensitivity, 99.8% specificity. 100 µL sample, 105-minute assay. TFDA & CE certified.

PRODUCT DESCRIPTION

This product is a direct sandwich ELISA reagent for qualitative detection of Anti-HCV antibodies in human serum or plasma, intended for identifying current or past infection. It uses a 100 µL sample volume with a 105-minute incubation and read wavelength at 450 nm. Clinical validation shows 100% sensitivity and 99.8% specificity. Certified under TFDA and CE 0344. Non-Reactive results indicate absence of detectable Anti-HCV antibody; Reactive results confirm presence and should be interpreted in conjunction with clinical findings and additional diagnostics.

SPECIFICATION

✱Notified body: 0344

Number of wells96 / 480
PrincipleDirect Sandwich
Assay formatQualitative
Total incubation time105 minutes
Sample typeSerum / Plasma
Sample volume100 μL
Reading wavelength450 nm
Storage2-8°C
CertificationTFDA / CE marked ✱

PERFORMANCE

The diagnostic sensitivity is 100%;The diagnostic specificity is 99.8%

PrecisionVariability%CV
Repeatabilitywithin run<10%
Reproducibilitybetween-day<20%
between-run<20%
between-sites<15%
between-operators<15%
between-lots<15%

ORDERING INFORMATION

Catalogue No.Product
4NAE3NANBASE C-96 V4.0 (Anti-HCV) – 96T
4NAE12NANBASE C-96 V4.0 (Anti-HCV) – 480T